Association between endothelin type A receptor haplotypes and mortality in coronary heart disease

Personalized Medicine
Katrina L EllisVicky A Cameron

Abstract

The endothelin type A receptor, encoded by EDNRA, mediates the effects of endothelin-1 to promote vasoconstriction, vascular cell growth, adhesion, fibrosis and thrombosis. We investigated the association between EDNRA haplotype and cardiovascular outcomes in patients with coronary artery disease. Coronary disease patients (n = 1007) were genotyped for the His323His (rs5333) variant and one tag SNP from each of the major EDNRA haplotype blocks (rs6537484, rs1568136, rs5335 and rs10003447). EDNRA haplotype associations with clinical history, natriuretic peptides cardiac function and cardiovascular outcomes were tested over a median 3.8 years. Univariate analysis identified a 'low-risk' EDNRA haplotype associated with later age of Type 2 diabetes onset (p = 0.004) smaller BMI (p = 0.021), and reduced mortality (log rank p = 0.001). Cox proportional hazards analysis including established cardiovascular risk factors revealed an independent association between haplotype and mortality (p < 0.0001). These data highlight the potential importance of the endothelin system, and in particular EDNRA in coronary disease.

References

Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A InoueT Masaki
Sep 1, 1989·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·N B SchillerI Schnittger
Jun 26, 1997·The American Journal of Cardiology·P K Shah
Apr 1, 1999·Annual Review of Physiology·T Miyauchi, T Masaki
Mar 20, 2001·American Journal of Human Genetics·M StephensP Donnelly
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·R M Kedzierski, M Yanagisawa
Oct 5, 2001·Nature Genetics·G C JohnsonJ A Todd
Oct 6, 2001·The New England Journal of Medicine·J A de LemosE Braunwald
May 25, 2002·Science·Stacey B GabrielDavid Altshuler
Dec 20, 2003·Nature·UNKNOWN International HapMap Consortium
Aug 7, 2004·Bioinformatics·J C BarrettM J Daly
Feb 9, 2005·American Journal of Human Genetics·Matthew Stephens, Paul Scheet
Oct 7, 2005·Journal of Hypertension·Olivier OrmezzanoJean Philippe Baguet
Mar 1, 2007·Diabetes·Amale LteifKieren J Mather

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
pharmacotherapy

Software Mentioned

GeneMapper
PHASE
SPSS
Haploview

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

Scandinavian Cardiovascular Journal : SCJ
John Pernow
BMJ : British Medical Journal
D E Newby, D J Webb
Current Opinion in Cardiology
Brian L StaufferChristopher A DeSouza
© 2022 Meta ULC. All rights reserved